Literature DB >> 24896361

MicroRNA in hepatic fibrosis and cirrhosis.

Xuan Xin, Yongxian Zhang, Xiaohong Liu, Haixia Xin, Yongcheng Cao, Ming Geng.   

Abstract

Hepatic fibrosis is caused by an imbalance between production and dissolution of extracellular matrix after chronic and inflmmatory injury, when hepatic stellate cells are stimulated to proliferate and secret extracellular matrix. The most common causes of liver fibrosis are chronic viral hepatitis B and C. Cirrhosis is the most advanced stage of fibrosis, which usually develop into hepatocellular carcinoma (HCC). microRNAs participate the pathogenesis of hepatic fibrosis and cirrhosis or even the onset of HCC. In this review, we will summarize the role of miRNA in the pathogenesis of viral hepatitis fibrosis, non-alcoholic steatohepatitis fibrosis, primary biliary cirrhosis and HCC onset, especially in the regulation of stellate cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24896361     DOI: 10.2741/4292

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  7 in total

Review 1.  Micro RNAs in the development of non-alcoholic fatty liver disease.

Authors:  Glenn S Gerhard; Johanna K DiStefano
Journal:  World J Hepatol       Date:  2015-02-27

2.  MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis.

Authors:  Shuang Ren; Jiamei Chen; Qinglan Wang; Xuewei Li; Ying Xu; Xiao Zhang; Yongping Mu; Hua Zhang; Shuang Huang; Ping Liu
Journal:  Hepatol Int       Date:  2019-10-23       Impact factor: 6.047

3.  Sulforaphane inhibits the activation of hepatic stellate cell by miRNA-423-5p targeting suppressor of fused.

Authors:  Ming-Hui Feng; Jian-Wei Li; Hai-Tao Sun; Song-Qi He; Jie Pang
Journal:  Hum Cell       Date:  2019-07-05       Impact factor: 4.174

Review 4.  The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis.

Authors:  Kurt Sartorius; Julia Makarova; Benn Sartorius; Ping An; Cheryl Winkler; Anil Chuturgoon; Anna Kramvis
Journal:  Cells       Date:  2019-11-24       Impact factor: 6.600

Review 5.  The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis.

Authors:  Joeri Lambrecht; Inge Mannaerts; Leo A van Grunsven
Journal:  Front Physiol       Date:  2015-07-28       Impact factor: 4.566

6.  Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis.

Authors:  Yehong Liu; Puye Yang; Na Chen; Shumei Lin; Min Liu
Journal:  Int J Mol Med       Date:  2016-08-26       Impact factor: 4.101

Review 7.  Epigenetics in liver disease: from biology to therapeutics.

Authors:  Timothy Hardy; Derek A Mann
Journal:  Gut       Date:  2016-09-13       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.